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Introduction
The tumor suppressor p53 typically triggers apoptosis, cell cycle 
arrest, or senescence in response to the activation of oncogenes 
such as ras. This ultimately prevents tumorigenesis (Meek, 2009). 
In addition to its role in blocking tumorigenesis, p53 hampers 
malignant phenotypes such as tumor invasion and metastasis 
(Muller et al., 2011). In some cases, even in the presence of wild-
type TP53—the gene that encodes p53—transformation is induced 
when the ability of p53 to suppress tumorigenesis is somehow 
compromised. Mutations in TP53 are observed in 50% of human 
cancers and frequently occur in late stages of a variety of cancers, 
including colorectal, pancreatic, and breast cancers (Rivlin et al., 
2011). Missense mutations in Ras oncogenes, resulting in their 
aberrant activation, are observed in 30% of human cancers. 
Oncogenic Ras not only induces cellular transformation but also 
promotes tumor cell invasion and metastasis (Campbell and Der, 
2004). Although much is known about the mechanism by which 
p53 prevents Ras transformation, less is known about how p53 
suppresses Ras-driven invasion.
Integrins are essential for cell invasion, not only because 
they mediate adhesion to the ECM, but also because they initiate 
intracellular signals that regulate actin and adhesion dynamics 
(Guo and Giancotti, 2004). Upon binding to the ECM, integrins 
recruit a large number of signaling proteins such as p130 Crk-
associated substrate (p130Cas) and FAK to form integrin adhe-
sion complexes. p130Cas is a major substrate of Src at integrin 
adhesion complexes and Src-mediated tyrosine phosphorylation 
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required for the p53-mediated suppression of cell invasion, and 
this reflects a novel role of p53 in suppressing the malignancy 
of transformed cells.
Results
p53 is involved in Ras-induced down-
regulation of p130Cas phosphorylation
Oncogenic Ras transforms immortal rodent cells expressing 
wild-type p53, as well as p53-deficient cells, but induces se-
nescence or apoptosis in primary rodent cells expressing wild-
type p53 (Sherr, 1998). To investigate the mechanism by which 
p53 prevents invasion of Ras-transformed cells, we transformed 
p53-deficient (p53/) mouse embryonic fibroblasts (MEFs), 
NIH3T3 cells, and immortalized wild-type MEFs (iMEFs) 
by introducing the activated form of Ha-Ras (Ha-RasV12). 
NIH3T3 cells and iMEFs are spontaneously immortalized 
MEFs and express wild-type p53. The invasiveness of Ras-
transformed p53/ MEFs into 3D matrices was higher than that 
of Ras-transformed NIH3T3 cells or iMEFs (Fig. 1, A and B). 
The expression of a cancer-associated mutant p53 (p53R175H), 
which acts as a dominant-negative form, increased the inva-
siveness of Ras-transformed NIH3T3 cells (Fig. 1, C and D). 
These results indicate that p53 prevents the invasiveness of Ras-
transformed cells.
Reorganization of the actin cytoskeleton and focal adhe-
sions (FAs) is commonly observed during cell transformation 
(Pawlak and Helfman, 2001). We therefore compared the actin 
architecture and FAs between the Ras-transformed cells. 
NIH3T3 cells and iMEFs, after transformation by oncogenic 
Ras, exhibited poorly spread morphologies (Fig. S1 A) and 
decreased formation of actin stress fibers and FAs (Fig. 2, 
A and B). However, in p53/ MEFs, FA formation remained upon 
Ras transformation while actin stress fiber formation decreased. 
We then examined the status of FA proteins and showed that 
phosphorylation of p130Cas was reduced in Ras-transformed 
NIH3T3 cells and iMEFs, but not p53/ MEFs (Fig. 2, B and C). 
In contrast, all cells irrespective of p53 expression showed a 
slight decrease in the phosphorylation of FAK, which is an-
other FA protein, upon Ras transformation (Fig. 2 C). Further-
more, all cells showed an increase in the activity of Src, 
suggesting that the decreased phosphorylation of p130Cas is un-
likely due to a down-regulation of Src activity. The expression of 
p53R175H restored both FA formation and p130Cas phosphory-
lation (Fig. 2, D and E), which were decreased after oncogenic 
Ras transformation in NIH3T3 cells (Fig. 2, B and C). These re-
sults show that p53 is involved in the down-regulation of 
p130Cas phosphorylation and FA formation after Ras transfor-
mation. Because p130Cas is known to promote cancer cell inva-
sion (Defilippi et al., 2006), we wondered whether p130Cas 
is involved in the enhanced invasiveness of Ras-transformed 
cells when wild-type p53 function is lost. We found that knock-
down of p130Cas suppressed the invasion of Ras-transformed 
NIH3T3 cells expressing p53R175H (Fig. 2, F–H) and the inva-
sion of Ras-transformed p53/ MEFs (Fig. 2, I–K), suggesting 
that p53 suppresses Ras-driven invasion by down-regulating 
p130Cas phosphorylation.
of p130Cas initiates Rac activation to promote lamellipodia 
formation (Sharma and Mayer, 2008). Moreover, p130Cas 
confers an invasive phenotype in cancer cells (Cabodi et al., 
2010). The integrin adhesion complexes, of which p130Cas is 
a component, activate a range of Rho GTPases, including Rho, 
Rac, and Cdc42. Rho GTPases drive changes in cell shape dur-
ing cell movement by controlling actin polymerization and 
actomyosin contraction.
High-temperature requirement A2 (HtrA2)/Omi is a ser-
ine protease and chaperone protein (Vande Walle et al., 2008) 
that has a mitochondrial targeting sequence and transmem-
brane domain in the N-terminal region. It is initially synthesized 
as a precursor protein with a predicted molecular weight of 
49 kD. The mature 36-kD form of HtrA2/Omi is generated after 
its posttranslational translocation into mitochondria and sub-
sequently resides in the mitochondrial intermembrane space 
(IMS). HtrA2/Omi maintains mitochondrial homeostasis in-
cluding mitochondrial respiration; however, under stress condi-
tions, HtrA2/Omi promotes apoptosis. In the presence of apoptotic 
stimuli, HtrA2/Omi is released from mitochondria into the 
cytosol, where it binds to and cleaves inhibitor of apoptosis 
proteins (IAPs), such as X-IAP, and activates caspases. Overex-
pression of mature HtrA2/Omi also induces cell rounding 
through its protease activity (Suzuki et al., 2001). This occurs 
without caspase activation. Proteomic analysis identified cyto-
skeletal proteins including -actin as substrates of HtrA2/Omi 
(Vande Walle et al., 2007), raising the possibility that the mor-
phological change induced by HtrA2/Omi is due to proteolysis 
of cytoskeletal proteins.
Mitochondria are dynamic organelles that undergo con-
tinuous cycles of fission and fusion (Westermann, 2010). Mito-
chondrial fission results from the constriction of mitochondria 
by the dynamin-related GTPase dynamin-related protein 1 (Drp1), 
and mitochondrial fusion is mediated by other dynamin-related 
GTPases such as mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2). 
This dynamic behavior enables daughter cells to inherit mito-
chondria after cell division and maintains the metabolic func-
tions of mitochondria, including ATP synthesis. Furthermore, 
mitochondrial fission is often promoted during the early stages 
of apoptosis. This is commonly observed before caspase activa-
tion, and is known to induce mitochondrial outer membrane 
permeabilization (MOMP; Martinou and Youle, 2011). MOMP 
leads to the release of IMS proteins such as cytochrome c and 
HtrA2/Omi into the cytosol. Cytosolic cytochrome c induces 
caspase activation and further promotes MOMP, resulting in a 
robust release of IMS proteins and apoptosis (Tait and Green, 
2010). Mitochondrial dynamics therefore play an integral role 
in cell homeostasis, and indeed perturbation of the mito-
chondrial fission–fusion balance results in mitochondrial frag-
mentation, which is associated with many disease conditions 
(Westermann, 2010).
Oncogenic Ras promotes actin reorganization to promote 
cell invasion (Campbell and Der, 2004). Concurrently, onco-
genic Ras induces a p53-mediated alteration of the actin cyto-
skeleton via HtrA2/Omi, which hampers cell invasion. In this 
study, we show the opposing effects of oncogenic Ras on cell 
invasion. Ras-induced disruption of mitochondrial integrity is 
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significantly activate caspase-3 and treatment with the DNA-
damaging agent Adriamycin activated caspase-3 but did not 
increase -actin cleavage in nontransformed cells (Fig. S3 A). 
We therefore examined whether HtrA2/Omi is involved in p53-
dependent cleavage of -actin, which results in down-regulation 
of p130Cas phosphorylation upon Ras transformation. Knock-
down of HtrA2/Omi did not affect phosphorylation of p130Cas 
in nontransformed cells (Fig. 4 E). In contrast, knockdown of 
HtrA2/Omi restored down-regulated p130Cas phosphorylation 
induced by oncogenic Ras and diminished the cleavage of 
-actin (Fig. 4, E and F). The HtrA2/Omi inhibitor Ucf-101 also 
diminished the cleavage of -actin and increased phosphory-
lation of p130Cas in Ras-transformed cells (Fig. 4, G and H). 
These results suggest that HtrA2/Omi cleaves -actin after on-
cogenic Ras transformation.
Because cleavage of -actin seems to correlate with p130Cas 
phosphorylation, we wondered whether knockdown of HtrA2/
Omi has an impact on F-actin and lamellipodia formation. Knock-
down of HtrA2/Omi increased the amount of F-actin and the ratio 
of F/G-actin (Fig. 4, I–K; Fig. S2 C) and facilitated the formation 
of lamellipodia and FAs, but not stress fibers, in Ras-transformed 
NIH3T3 cells (Fig. 4, I [middle], L, and M), as was the case with 
the introduction of p53R175H (Fig. 2 D; Fig. 3 E, middle). Taken 
together, these results suggest that, upon Ras transformation, 
HtrA2/Omi cleaves -actin in a p53-dependent manner and di-
minishes F-actin formation, resulting in down-regulation of 
p130Cas phosphorylation.
HtrA2/Omi suppresses invasion of  
Ras-transformed cells
We next examined role of HtrA2/Omi in the invasion of Ras-
transformed cells. The invasiveness of Ras-transformed NIH3T3 
cells was increased by knockdown of HtrA2/Omi (Fig. 4, N 
p53 is required for HtrA2/Omi-mediated  
-actin cleavage after Ras transformation
Phosphorylation of FA proteins is affected by actin cytoskeleton 
dynamics (Vuori and Ruoslahti, 1995; Parsons et al., 2010). 
Treatment of NIH3T3 cells with blebbistatin, a myosin II in-
hibitor, reduced phosphorylation of FAK, but did not affect 
phosphorylation of p130Cas (Fig. 3 A). By contrast, when actin 
polymerization was inhibited by treatment with cytochalasin D 
or latrunculin A, phosphorylation of both p130Cas and FAK 
was diminished. These results suggest that the formation of 
F-actin is important for phosphorylation of p130Cas. We found 
that oncogenic Ras decreased the amount of F-actin and the ratio 
of F-actin to globular actin (G-actin) in NIH3T3 cells and iMEFs 
but not in p53/ MEFs (Fig. 3, B–D; Fig. S2 A). Introducing 
p53R175H increased the amount of F-actin and the F/G-actin 
ratio in Ras-transformed NIH3T3 cells (Fig. 3, E–G; Fig. S2 B). 
Phosphorylation of p130Cas increased when F-actin was sta-
bilized by treatment with jasplakinolide in Ras-transformed 
NIH3T3 cells (Fig. 3 H). Collectively, these results suggest that 
p53 mediates the Ras-induced decrease in F-actin and thereby 
suppresses phosphorylation of p130Cas.
We found that oncogenic Ras induced the cleavage of 
-actin in NIH3T3 cells and iMEFs but not p53/ MEFs (Fig. 4, 
A and B). The cleavage of -actin in Ras-transformed NIH3T3 
cells was diminished by expressing p53R175H (Fig. 4, C and D). 
We therefore hypothesized that p53-dependent cleavage of -actin 
causes a decrease in the amount of F-actin and consequently de-
creases phosphorylation of p130Cas in Ras-transformed cells. 
Previous studies have shown that -actin is cleaved by the prote-
ases caspase-3 and HtrA2/Omi, yielding fragments of 30 kD 
from its C-terminal end (Enoksson et al., 2007; Vande Walle et al., 
2007). However, caspase-3 was unlikely to be involved in Ras-
induced cleavage of -actin because oncogenic Ras did not 
Figure 1. p53 suppresses Ras-driven invasion. (A and B) NIH3T3 cells, iMEFs, and p53/ MEFs were infected with a control or Ha-RasV12–expressing 
retrovirus. (C and D) NIH3T3 cells were infected with a Ha-RasV12–expressing retrovirus together with a control or p53R175H-expressing retrovirus. 
(A and C) Inverted invasion assays were performed. Images of serial Z-sections (10-µm intervals). Bars, 100 µm. (B and D) Cells invaded 30 µm or more 
were quantified. Data represent the mean ± SD; n = 3. *, P < 0.05.
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Figure 2. Oncogenic Ras decreases phosphorylation of p130Cas in a p53-dependent manner. (A–C) NIH3T3 cells, iMEFs, and p53/ MEFs were infected 
with a control or Ha-RasV12–expressing retrovirus. (D and E) NIH3T3 cells were infected with a Ha-RasV12–expressing retrovirus together with a control or 
p53R175H-expressing retrovirus. (A, B, and D) Confocal images of cells stained for F-actin (A) or for paxillin and phosphorylated p130Cas (p-p130Cas; 
B and D). Bars, 20 µm. (C and E) Levels of phosphorylated p130Cas, phosphorylated FAK (p-FAK), and phosphorylated Src (p-Src) were evaluated by immuno-
blotting. Blots of phosphorylated p130Cas and p130Cas were quantified and the relative values of p130Cas phosphorylation are shown. (F–H) NIH3T3 
cells were infected with Ha-RasV12– and p53R175H-expressing retroviruses together with a control or p130Cas shRNA–expressing retrovirus. (I–K) p53/ 
MEFs were infected with a Ha-RasV12–expressing retrovirus together with a control or p130Cas shRNA–expressing retrovirus. (F and I) The level of p130Cas 
expression was evaluated by immunoblotting. (G and J) Inverted invasion assays were performed. Images of serial Z-sections (10-µm intervals). Bars, 100 µm. 
(H and K) Cells invaded 30 µm or more were quantified. Data represent the mean ± SD; n = 5 (H) or n = 3 (K). *, P < 0.05.
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middle). Oncogenic Ras promotes cell invasion by increasing 
matrix degradation and migration regulated by multiple down-
stream molecules including Rho GTPases (Campbell and Der, 
2004). In this context, our results suggest that p130Cas has an 
integral role to play in Ras-driven invasion, though it is not the 
sole molecule responsible for this process.
Because the formation of lamellipodia, which are key struc-
tures for cancer cell invasion (Olson and Sahai, 2009; Petrie and 
[bottom] and O). This was abolished by knockdown of p130Cas 
(Fig. 4, P–R), suggesting that HtrA2/Omi prevents Ras-driven 
invasion via down-regulation of p130Cas phosphorylation. 
Even though phosphorylation of p130Cas in nontransformed 
cells was higher than that in Ras-transformed cells (Fig. 2 C), 
nontransformed NIH3T3 cells were not invasive (Fig. 4 N, top) 
as previously reported (Albini et al., 1987) and Ras-transformed 
cells invaded to a modest though significant extent (Fig. 4 N, 
Figure 3. Oncogenic Ras decreases the amount of F-actin in a p53-dependent manner. (A) NIH3T3 cells were treated with 0.5 µM cytochalasin D, 0.2 µM 
latrunculin A, or 50 µM blebbistatin for 30 min. The levels of phosphorylated p130Cas (p-p130Cas) and phosphorylated FAK (p-FAK) were evaluated 
by immunoblotting. (B–D) NIH3T3 cells, iMEFs, and p53/ MEFs were infected with a control or Ha-RasV12–expressing retrovirus. (E–G) NIH3T3 cells 
were infected with a Ha-RasV12–expressing retrovirus together with a control or p53R175H-expressing retrovirus. (B and E) Cells were stained for F-actin 
(middle) and G-actin (bottom). Ratio images of F/G-actin (top). Bars, 20 µm. (C, D, F, and G) Intensity ratios of F/G-actin (C and F) or F-actin (D and G) 
were quantified from images in B and E. Values were normalized with the mean value of the control cells. Data represent the mean ± SD of >28 cells. 
*, P < 0.01. (H) Ras-transformed NIH3T3 cells were treated with 50 nM jasplakinolide for 2 h. The level of phosphorylated p130Cas was evaluated 
by immunoblotting.
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Figure 4. Knockdown of HtrA2/Omi attenuates the cleavage of -actin and restores p130Cas phosphorylation in Ras-transformed cells. (A and B) 
NIH3T3 cells, iMEFs, and p53/ MEFs were infected with a control or Ha-RasV12–expressing retrovirus. (C and D) NIH3T3 cells were infected with a 
Ha-RasV12–expressing retrovirus together with a control or p53R175H-expressing retrovirus. (E) NIH3T3 cells were infected with a control or Ha-RasV12–
expressing retrovirus together with a control or HtrA2/Omi shRNA–expressing retrovirus. (F, and I–M) NIH3T3 cells were infected Ha-RasV12–expressing 
retrovirus and a control or HtrA2/Omi shRNA–expressing retrovirus. (G and H) NIH3T3 cells infected with Ha-RasV12–expressing retrovirus were treated 
with 50 µM Ucf-101 for 2 h. (N and O) NIH3T3 cells were infected with a control or Ha-RasV12–expressing retrovirus and a control or HtrA2/Omi 
shRNA–expressing retrovirus. (P–R) NIH3T3 cells were infected with Ha-RasV12– and HtrA2/Omi shRNA–expressing retroviruses together with a control or 
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HtrA2/Omi knockdown and instead filopodia formation was pro-
moted in these cells (Fig. 5, A–C, middle; Videos 1–3), without 
any alteration in the amount of F-actin or the ratio of F/G-actin 
(Fig. 5, C–E; Fig. S2, D and E). Similar effects of p130Cas 
knockdown were observed in Ras-transformed NIH3T3 cells 
Yamada, 2012), is facilitated by p53R175H expression or HtrA2/
Omi knockdown in Ras-transformed cells (Fig. 3 E, middle; Fig. 4, 
I [middle] and L), we next examined role of p130Cas in lamel-
lipodia formation. We found that knockdown of p130Cas ham-
pered lamellipodia formation in Ras-transformed cells with 
p130Cas shRNA–expressing retrovirus. (A, C, F, and H) The cleavage of -actin was evaluated by immunoblotting. Black arrowheads indicate full-length 
-actin, and white arrowheads indicate cleaved fragments. (B and D) The amount of cleaved fragments of -actin relative to the total amount of -actin was 
evaluated. Data represent the mean ± SD; n = 4; *, P < 0.01. (E and G) The levels of phosphorylated p130Cas (p-p130Cas; E and G) and HtrA2/Omi 
(E) were evaluated by immunoblotting. Blots of phosphorylated p130Cas and p130Cas were quantified and the relative values of p130Cas phosphory-
lation are shown. (I) Cells were stained for F-actin (middle) and G-actin (bottom). Ratio images of F/G-actin (top). Bar, 20 µm. (J and K) F/G-actin ratio 
(J) or F-actin (K) values were normalized with the mean value of the control cells. Data represent the mean ± SD of more than 30 cells. *, P < 0.01. 
(L and M) Confocal images of cells stained for F-actin (L) or for paxillin and phosphorylated p130Cas (M). Enlarged images of top panel were shown in 
bottom panel. Arrowheads indicate lamellipodia. Bars, 20 µm. (N and Q) Inverted invasion assays were performed. Images of serial Z-sections (10-µm 
intervals). Bars, 100 µm. (O and R) Cells invaded 30 µm or more were quantified. Data represent the mean ± SD; n = 3. *, P < 0.01. (P) The expression 
level of p130Cas was evaluated by immunoblotting.
 
Figure 5. Knockdown of p130Cas suppresses lamellipodia formation in Ras-transformed cells. (A–E) NIH3T3 cells were infected with Ha-RasV12– and 
HtrA2/Omi shRNA–expressing retroviruses together with a control or p130Cas shRNA–expressing retrovirus. (F–J) NIH3T3 cells were infected with Ha-
RasV12– and p53R175H-expressing retroviruses together with a control or p130Cas shRNA–expressing retrovirus. (A and F) Confocal images of cells 
stained for F-actin. Arrowheads indicate lamellipodia. Bar, 20 µm. (B and G) Cells were transfected with a Lifeact-GFP expression vector to label F-actin. 
Single section of protrusions from Videos 2 and 3 (B) or Videos 4 and 5 (G). Bars, 10 µm. (C and H) Cells were stained for F-actin (middle) and G-actin 
(bottom). Ratio images of F/G-actin (top). Bars, 20 µm. (D, E, I, and J) Intensity ratios of F/G-actin (D and I) or F-actin (E and J) were quantified from images 
in C and H. Values were normalized with the mean value of the control cells. Data represent the mean ± SD; n = 28 cells.
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from apoptotic stimuli. Because mitochondrial fission promotes 
MOMP (Martinou and Youle, 2011), we examined the effect of 
oncogenic Ras on mitochondrial morphology in NIH3T3 cells. 
In control cells, mitochondria were frequently observed as long, 
snake-like tubules whereas in Ras-transformed cells, mitochon-
dria mostly appeared small and spherical (Fig. 6 B). Overexpres-
sion of Mfn2 promotes mitochondria fusion and attenuated both 
the release of HtrA2/Omi from mitochondria and cleavage of 
-actin in Ras-transformed cells (Fig. 6, C–E). These results sug-
gest that oncogenic Ras promotes mitochondrial fission to induce 
the release of HtrA2/Omi into the cytosol.
p53 is involved in Ras-induced 
translocation of p38 MAPK into 
mitochondria and phosphorylation  
of HtrA2/Omi
Overexpression of p53 is known to induce the release of HtrA2/
Omi from mitochondria (Marabese et al., 2008). However, in 
Ras-transformed p53/ MEFs, mitochondria appeared small and 
spherical (Fig. 7 A) and HtrA2/Omi was released from mitochon-
dria into the cytosol (Fig. 7, B–D, top), as was observed in Ras-
transformed NIH3T3 cells. These results indicate that p53 is not 
required for Ras-induced release of HtrA2/Omi.
expressing p53R175H (Fig. 5, F–J; Videos 4 and 5). In addition, 
a decrease in the cell-spreading area upon oncogenic Ras trans-
formation in a p53- or HtrA2/Omi-dependent manner was not af-
fected by knockdown of p130Cas (Fig. S1, B–D). These results 
suggest that HtrA2/Omi decreases F-actin and hampers lamelli-
podia formation through down-regulation of p130Cas signaling, 
resulting in restricted Ras-driven invasion.
Oncogenic Ras induces the release  
of HtrA2/Omi from mitochondria  
into the cytosol by promoting  
mitochondrial fragmentation
Given the cleavage of -actin by HtrA2/Omi, we hypothesized 
that the release of HtrA2/Omi into the cytosol is induced by on-
cogenic Ras. We found that the amount of HtrA2/Omi in the 
cytosolic fraction was increased upon Ras transformation in 
NIH3T3 cells (Fig. 6 A). The release of IMS proteins, including 
HtrA2/Omi and cytochrome c, requires MOMP (Tait and Green, 
2010). Unlike with MOMP induced by apoptotic stimuli, a robust 
release of cytochrome c was not observed in Ras-transformed 
cells regardless of the presence or absence of the pan-caspase in-
hibitor Q-VD-OPh (Fig. S3 B). MOMP after activation of Ras 
may therefore be mechanistically different from that resulting 
Figure 6. Oncogenic Ras enhances the re-
lease of HtrA2/Omi from mitochondria into 
the cytosol. (A and B) NIH3T3 cells were in-
fected with a control or Ha-RasV12–expressing 
retrovirus. (C–E) Ras-transformed NIH3T3 cells 
were transfected with a control or Flag-tagged 
Mfn2 expression vector and cultured for 36 h. 
(A and D) After subcellular fractionation of the 
cytosol (Cyto) and mitochondria (Mito), the 
distribution of HtrA2/Omi was evaluated by 
immunoblotting. COX IV and -tubulin were 
used as mitochondrial and cytosolic markers, 
respectively. (B and C) Cells were transfected 
with a Mito-DsRed expression vector to visual-
ize mitochondria. Images were obtained by 
three-dimensional structured illumination mi-
croscopy (top). Bars (main panels and insets), 
10 µm. Colors indicate the lengths of mitochon-
dria. Insets show the raw fluorescence images. 
Data represent the mean ± SEM (bottom); n = 5. 
(E) The cleavage of -actin was evaluated by 
immunoblotting. Black arrowhead indicates full-
length -actin, and white arrowhead indicates 
a cleaved fragment.
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Mitochondrial serine/threonine protein kinase PTEN- 
induced putative kinase 1 (PINK1) has been shown to be es-
sential for p38 MAPK-induced HtrA2/Omi phosphorylation 
(Plun-Favreau et al., 2007). Oncogenic Ras increased HtrA2/
Omi phosphorylation in both the cytosol and mitochondria of 
NIH3T3 cells but not in p53/ MEFs (Fig. 7, D and E), whereas 
levels of phosphorylated p38 MAPK—the active form of p38 
MAPK—were comparable between NIH3T3 cells and p53/ 
MEFs (Fig. 7 E). We therefore hypothesized that oncogenic Ras 
induces the translocation of p38 MAPK into mitochondria in a 
HtrA2/Omi is phosphorylated at Ser 142 by p38 MAPK, 
which increases the protease activity of HtrA2/Omi (Plun-Favreau 
et al., 2007). We then examined whether oncogenic Ras induces 
the activation of HtrA2/Omi in a p53-dependent manner. Onco-
genic Ras increased phosphorylation of HtrA2/Omi at Ser 142 
in NIH3T3 cells but not in p53/ MEFs (Fig. 7 E, top). More-
over, the increased phosphorylation in Ras-transformed NIH3T3 
cells was diminished by expressing p53R175H (Fig. 7 F, top). 
Collectively, these results indicate that p53 is required for acti-
vation of HtrA2/Omi induced by oncogenic Ras.
Figure 7. Oncogenic Ras increases mitochondrial translocation of p38 MAPK and phosphorylation of HtrA2/Omi in a p53-dependent manner.  
(A–E) NIH3T3 cells and p53/ MEFs were infected with a control or Ha-RasV12–expressing retrovirus. (F) NIH3T3 cells were infected with a Ha-RasV12– 
expressing retrovirus together with a control or p53R175H-expressing retrovirus. (G and H) Ras-transformed NIH3T3 cells were treated with 10 µM BIRB796 
for 16 h. (A) p53/ MEFs were transfected with a Mito-DsRed expression vector to visualize mitochondria. Images were obtained by three-dimensional 
structured illumination microscopy (top). Bars (main panel and inset), 10 µm. Colors indicate the lengths of mitochondria. Insets show the raw fluorescence 
images. Data represent the mean ± SEM (bottom); n = 5. (B) Confocal images of cells stained for HtrA2/Omi. Bars (top), 10 µm. The square region in the 
top panel is shown magnified in the bottom panel. Bars (bottom), 1 µm. (C) Relative fluorescence intensities in the cytosol were calculated from the images 
in B. Data represent the mean ± SD of more than 15 cells. *, P < 0.01. (D) The distribution of HtrA2/Omi and p38 MAPK, and the levels of phosphorylated 
HtrA2/Omi (p-HtrA2) and phosphorylated p38 MAPK (p-p38), were evaluated by immunoblotting after subcellular fractionation of the cytosol (Cyto) and 
mitochondria (Mito). COX IV and -tubulin were used as mitochondrial and cytosolic markers, respectively. (E and F) The levels of phosphorylated HtrA2/
Omi and phosphorylated p38 MAPK were evaluated by immunoblotting. Black arrowheads indicate phosphorylated HtrA2/Omi. The level of phosphory-
lated HtrA2/Omi in the mitochondrial fraction was also evaluated. (G) The level of phosphorylated HtrA2/Omi in the mitochondrial fraction was evaluated 
by immunoblotting. (H) The cleavage of -actin was evaluated by immunoblotting. Black arrowhead indicates full-length -actin, and white arrowhead 
indicates a cleaved fragment. The relative amount of the cleaved fragment of -actin to the total amount of -actin was quantified.
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treatment with BIRB796, an inhibitor of p38 MAPK, diminished 
Ras-induced phosphorylation of HtrA2/Omi in mitochondria 
and cleavage of -actin (Fig. 7, G and H). These results suggest 
that p53 mediates -actin cleavage via activation of HtrA2/Omi, 
which is induced by mitochondrial p38 MAPK after oncogenic 
Ras transformation.
Next, we examined the direct effects of HtrA2/Omi on the 
cleavage of -actin. The exogenous mature form of HtrA2/Omi, 
which is diffusely distributed in cells (Suzuki et al., 2001), in-
creased the cleavage of -actin in Ras-transformed cells ex-
pressing p53R175H (Fig. 8 A). The phosphomimetic mutant of 
p53-dependent manner. Furthermore, we believed the subse-
quent phosphorylation of HtrA2/Omi occurred in mitochondria, 
before its release into the cytosol. In line with this, we found 
that in NIH3T3 cells but not p53/ MEFs, oncogenic Ras in-
creased the amount of p38 MAPK and its phosphorylated form 
in the mitochondrial fraction (Fig. 7 D). These results suggest 
that oncogenic Ras induces phosphorylation of HtrA2/Omi by 
increasing the translocation of p38 MAPK into mitochondria in 
a p53-dependent manner. Consistent with this, p53R175H di-
minished Ras-induced phosphorylation of HtrA2/Omi in the 
mitochondrial fraction (Fig. 7 F). Furthermore, we showed that 
Figure 8. Expression of the phosphomimetic form of HtrA2/Omi enhances -actin cleavage and suppresses Ras-driven cell invasion. (A) Ras-transformed 
p53R175H-expressing cells were transfected with a Flag-tagged wild-type (WT) or S142D mature HtrA2/Omi (mHtrA2) expression vector. The cleavage 
of -actin was evaluated by immunoblotting. Black arrowhead indicates full-length -actin, and white arrowhead indicates a cleaved fragment. The relative 
amount of the cleaved fragment of -actin to the total amount of -actin was evaluated. Anti-Flag and anti-HtrA2/Omi antibodies were used to examine 
the expression level of exogenous HtrA2/Omi. Black arrows indicate exogenous HtrA2/Omi, and white arrow indicates endogenous HtrA2/Omi. N.S., 
nonspecific band. (B) Purified proteins of wild-type (WT), S306A, or S142D mature HtrA2/Omi were subjected to SDS-PAGE, followed by Coomassie 
brilliant blue (CBB) staining or anti-Flag immunoblotting. (C) Purified HtrA2/Omi proteins in B were incubated with F-actin for indicated time. Images were 
obtained by TIRF microscopy. Bar, 5 µm. (D) Serial time-lapse images of the actin filament in the red rectangle in C. Numbers indicate the time in seconds. 
Bar, 1 µm. (E) Fluorescence intensities after incubation with each form of purified HtrA2/Omi relative to fluorescence intensities before the incubation were 
calculated. Data represent the mean ± SD; n = 3. *, P < 0.05. (F and G) Ras-transformed p53/ MEFs were transfected with a control or Flag-tagged 
S142D mature HtrA2/Omi (mHtrA2) expression vector. (F) Inverted invasion assays were performed. Images of serial Z-sections (10-µm intervals). Bars, 
100 µm. (G) Cells that had invaded 30 µm or more were quantified. Data represent the mean ± SD; n = 3. *, P < 0.01.
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and Kroemer, 2009; Vaseva and Moll, 2009). Under stress condi-
tions, p53 translocates to mitochondria, contributing to the de-
crease in m. We found that p53 accumulated at mitochondria 
and in the cytosol in Ras-transformed NIH3T3 cells (Fig. 10 A). 
We then addressed whether cytoplasmic p53 is involved in the 
translocation of p38 MAPK into mitochondria after Ras trans-
formation. In Ras-transformed p53/ MEFs, the nuclear local-
ization signal (NLS) mutant of p53 (p53KRKKK) localized at 
mitochondria and in the cytosol and enhanced the translocation of 
p38 MAPK into mitochondria (Fig. 10, B and C), without the in-
duction of PUMA and BAX expression (Fig. S4 C). p53KRKKK 
increased phosphorylation of HtrA2/Omi in mitochondria and 
decreased the invasion of Ras-transformed p53/ MEFs (Fig. 10, 
D–F). Altogether, these results suggest that cytoplasmic p53 re-
stricts Ras-induced cell invasion through increasing p38 MAPK–
induced HtrA2/Omi activation in mitochondria.
Discussion
We have revealed a novel molecular mechanism by which p53 
suppresses Ras-driven invasion (Fig. 10 G). Upon Ras transfor-
mation, accumulation of p53 in the cytoplasm is induced, result-
ing in the activation of HtrA2/Omi via an increased translocation 
of p38 MAPK into mitochondria. Concurrently, oncogenic Ras 
induces mitochondrial fragmentation regardless of p53 expres-
sion. As a result, activated HtrA2/Omi is released from mitochon-
dria into the cytosol, where it induces F-actin disassembly. This 
leads to a down-regulation of p130Cas signaling, thereby sup-
pressing cell invasion through the impairment of lamellipodia 
formation. This p53-mediated pathway will play an important 
role in the suppression of malignancy when tumorigenesis is 
induced by oncogenic Ras.
Mitochondrial dysfunction induced by small molecule 
drugs including the F0 proton channel inhibitor oligomycin trig-
gers mitochondrial fragmentation without cell death (Fig. S5 A; 
De Vos et al., 2005). In addition, treatment with oligomycin in-
duces the release of HtrA2/Omi from mitochondria (Fig. S5 B). 
Because Ras transformation leads to mitochondrial dysfunction 
(Hu et al., 2012), it is likely that oncogenic Ras induces HtrA2/
Omi release through mitochondrial fragmentation caused by mito-
chondrial dysfunction.
Members of the pro-apoptotic Bcl2 family, including Bax 
and Bak, are major activators of MOMP and apoptosis (Tait and 
Green, 2010). After apoptotic stimuli, Bax is recruited from the 
cytosol to the outer mitochondrial membrane, where Bak is al-
ready present. Oligomerization of the two proteins promotes 
MOMP, leading to caspase activation, which follows the release 
of IMS proteins involving HtrA2/Omi. Oncogenic Ras induces 
the release of HtrA2/Omi without caspase activation (Fig. 7, B–D; 
Fig. S3), implying that MOMP after Ras transformation is 
mechanistically different from MOMP induced by apoptotic 
stimuli. Bax shuttles between the cytosol and mitochondrial fis-
sion sites and oligomerizes at the fission sites to induce MOMP 
(Martinou and Youle, 2011). GFP-tagged Bax (GFP-Bax) was 
diffusely distributed in nontransformed cells (Fig. S5 C), in line 
with a previous study (Perumalsamy et al., 2010), whereas it 
clearly localized to mitochondria in Ras-transformed cells or 
mature HtrA2/Omi (mHtrA2/Omi-S142D) was more potent in 
cleaving -actin (Fig. 8 A). To further examine whether HtrA2/
Omi affects the stability of F-actin, we incubated fluorescently la-
beled F-actin with a purified mature form of HtrA2/Omi (Fig. 8 B). 
Wild-type HtrA2/Omi induced disassembly of F-actin, with 
mHtrA2/Omi-S142D showing an even more prominent effect 
(Fig. 8, C [left and right] and E; Videos 6 and 8). The protease-
dead mutant of HtrA2/Omi (HtrA2/Omi-S306A) did not disas-
semble F-actin (Fig. 8, C [middle] and E; Video 7), indicating 
that HtrA2/Omi-induced disassembly of F-actin depends on its 
protease activity. Because mHtrA2/Omi-S142D induced frag-
mentation of F-actin (Fig. 8 D; Video 8), activated HtrA2/Omi 
is likely to cleave actin molecules in F-actin, thereby inducing 
its disassembly. Furthermore, we showed that mHtrA2/Omi-
S142D abolished the invasiveness of Ras-transformed p53/ 
MEFs (Fig. 8, F and G). These results support the notion that 
invasion of Ras-transformed cells is attenuated by the cleavage 
of -actin through activation of HtrA2/Omi.
Taken together, these results suggest that p53 mediates 
Ras-induced translocation of p38 MAPK into mitochondria and 
induces activation of HtrA2/Omi, resulting in down-regulation 
of p130Cas signaling via the disassembly of F-actin.
Cytoplasmic p53 promotes the 
translocation of p38 MAPK  
into mitochondria
We next investigated the mechanism by which p53 mediates 
Ras-induced translocation of p38 MAPK into mitochondria. 
Several studies show that p38 MAPK is present in mitochondria 
under stress conditions (Grethe et al., 2004; Kong et al., 2005). 
It is known that p53 mediates a stress-induced reduction of the 
inner mitochondrial membrane potential (m; Vousden and 
Lane, 2007; Vaseva and Moll, 2009), which is usually generated 
by the respiratory chain. We therefore examined m using 
JC-1. Cancer cells exhibit decreased oxidative phosphorylation, 
but maintain m (Fantin and Leder, 2006). Consistent with this, 
m in most mitochondria was maintained in Ras-transformed 
NIH3T3 cells (Fig. 9, A and B). However, m in mitochon-
dria at the cell periphery was decreased and this decrease was 
blocked by expressing p53R175H and abolished in p53/ 
MEFs, indicating that oncogenic Ras decreases m in a sub-
set of mitochondria within a cell in a p53-dependent manner. 
We showed that treatment with CCCP, which uncouples the 
proton gradient and dissipates m, promoted the transloca-
tion of p38 MAPK into mitochondria in Ras-transformed p53/ 
MEFs (Fig. 9 C). These results suggest that p53 mediates Ras-
induced translocation of p38 MAPK into mitochondria by de-
creasing m.
It is well known that p53 induces MOMP by inducing ex-
pression of its target genes, such as PUMA and BAX, resulting in 
a loss of m (Miyashita and Reed, 1995; Nakano and Vousden, 
2001; Vousden and Lane, 2007). Oncogenic Ras did not increase 
the expression of PUMA and BAX in both NIH3T3 cells and in 
p53/ MEFs (Fig. S4, A and B), suggesting that the decrease in 
m induced by oncogenic Ras may not be dependent on trans-
activation of p53 targets. In addition to its role as a transcription 
factor in the nucleus, p53 has functions in the cytoplasm (Green 
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mitochondrial outer membrane, p53 binds to Bcl-2 family mem-
bers and promotes Bax/Bak-induced MOMP. This will not occur 
after Ras transformation because neither the release of cyto-
chrome c nor activation of caspase is observed in Ras-transformed 
cells (Fig. S3). p53 also accumulates in the mitochondrial matrix, 
thereby inhibiting cyclophilin D, which is a regulator of the mito-
chondrial permeability transition pore (MPTP), and triggering the 
opening of MPTP (Vaseva et al., 2012). A decrease in m was 
observed in mitochondria at the cell periphery in Ras-transformed 
cells expressing p53 (Fig. 9 A). The subcellular heterogeneity of 
m is usually due to mitochondria interacting with other or-
ganelles, including the ER and acidic vesicular organelles (Keil 
et al., 2011). p53 is also known to localize at the ER or lysosome 
(Yamasaki et al., 2007; Johansson et al., 2010). Cytoplasmic 
p53 seems to contribute to the decrease in m by modulating 
these interactions in Ras-transformed cells. In addition, cytosolic 
p53 is known to inhibit the autophagic elimination of depolarized 
oligomycin-treated cells (Fig. S5, C and D). Bak is constitu-
tively down-regulated by oncogenic Ras (Liu et al., 2006). This 
suggests that oncogenic Ras-induced MOMP and HtrA2/Omi 
release involves Bax, but not Bak, and that oncogenic Ras func-
tions to suppress Bax/Bak-induced MOMP after apoptotic stimuli. 
Indeed, oncogenic Ras suppresses ECM detachment–induced 
anoikis, a form of apoptosis, via inhibition of HtrA2/Omi release, 
which is mediated by Bax and Bak (Gilmore et al., 2000; Liu et al., 
2006). Thus, oncogenic Ras controls the release of HtrA2/Omi 
through the regulation of a different type of MOMP.
Our results suggest that the mitochondrial translocation of 
p38 MAPK, which is induced by cytoplasmic p53 to activate 
HtrA2/Omi, is caused by a decrease in m (Fig. 9 C). This de-
crease in m is dispensable for HtrA2/Omi release from mito-
chondria (Fig. S5, B and E). In response to stress signals, p53 is 
known to rapidly translocate to mitochondria and decrease in 
m (Vaseva and Moll, 2009). When p53 accumulates in the 
Figure 9. Oncogenic Ras decreases mitochondrial membrane potential in a p53-dependent manner. (A and B) NIH3T3 cells were infected with a 
control or Ha-RasV12–expressing retrovirus together with a control or p53R175H-expressing retrovirus. p53/ MEFs were infected with a control or 
Ha-RasV12–expressing retrovirus. (A) Confocal images of cells stained with JC-1. The ratio of red fluorescence (J-aggregate) to green fluorescence (monomer) 
is correlated with mitochondrial membrane potential. Bars, 20 µm. (B) The ratio of red fluorescence to green fluorescence at peripheral mitochondria was 
quantified from images in A. Data represent the mean ± SD of more than 20 cells. *, P < 0.01. (C) Ras-transformed p53/ MEFs were treated with CCCP 
(20 µM) for 4 h. After subcellular fractionation of the cytosol (Cyto) and mitochondria (Mito), the distribution of p38 MAPK was evaluated by immuno-
blotting. COX IV and -tubulin were used as mitochondrial and cytosolic markers, respectively.
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actin (Vande Walle et al., 2007) as well as polymerized actin 
(Fig. 8, C–E), changes in the F-actin to G-actin ratio after Ras 
transformation appears to be associated with a decrease in not 
only F-actin, but also G-actin. As actin filament formation plays 
an important role in p130Cas phosphorylation, correlation be-
tween decreased p130Cas phosphorylation and the amount of 
F-actin, rather than the F-actin to G-actin ratio, is reasonable. 
Because immortal cells have genes with mutations, this may in-
fluence the cleavage of -actin in response to oncogenic Ras. 
mitochondria (Hoshino et al., 2013) and may facilitate the accumu-
lation of mitochondria with low m in Ras-transformed cells.
The cleavage of -actin after Ras transformation was ob-
served in both NIH3T3 cells and iMEFs expressing wild-type 
p53 (Fig. 4, A and B). The amount of -actin cleavage in 
NIH3T3 cells is higher than that in iMEFs and this is correlated 
with a decrease in the F-actin amount; however, the decrease in 
F/G-actin ratio was comparable between NIH3T3 cells and 
iMEFs (Fig. 3 C). Because HtrA2/Omi cleaves nonpolymerized 
Figure 10. Expression of p53KRKKK enhances mitochondrial translocation of p38 MAPK and phosphorylation of HtrA2/Omi in Ras-transformed cells.  
(A) NIH3T3 cells and p53/ MEFs were infected with a control or Ha-RasV12–expressing retrovirus. After subcellular fractionation of the cytosol (Cyto) and 
mitochondria (Mito), the distribution of p53 was evaluated by immunoblotting. Black arrowhead indicates nonspecific band (N.S.). COX IV and -tubulin 
were used as mitochondrial and cytosolic markers, respectively. (B–F) p53/ MEFs were infected with a Ha-RasV12–expressing retrovirus together with 
a control or p53KRKKK-expressing retrovirus. (B, top) DIC images of cells. Cell was stained for nucleus with DAPI (middle) or for p53 (bottom). Bar, 20 µm. 
(C) After subcellular fractionation of the cytosol and mitochondria, the distribution of p38 MAPK was evaluated by immunoblotting. (D) The level 
of phosphorylated HtrA2/Omi in the mitochondrial fraction was evaluated by immunoblotting. (E) Inverted invasion assays were performed. Images of 
serial Z-sections (10-µm intervals). Bars, 100 µm. (F) Cells invaded 30 µm or more were quantified from image in E. Data represent the mean ± SD; n = 3. 
*, P < 0.01. (G) Schematic of p53-mediated suppression of Ras-driven invasion via HtrA2/Omi. After Ras transformation, concurrent events of mitochondria 
fission and p53-mediated activation of HtrA2/Omi induced by p38 MAPK in mitochondria leads to the release of activated HtrA2/Omi. Consequentially, 
actin polymerization and p130Cas phosphorylation are inhibited, resulting in the suppression of invasion.
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Antibodies and materials
Anti-p130Cas rabbit polyclonal (Cas3), anti-phospho-FAK (Tyr 397) 
mouse monoclonal (EMD Millipore), anti-FAK mouse monoclonal (12G4; 
Abcam), anti–phospho-Src (Tyr 416) rabbit monoclonal (D49G4; Cell Sig-
naling Technology), anti-Src mouse monoclonal (GD11; EMD Millipore), 
anti–phospho-p38 (Thr 180/Tyr 182) rabbit monoclonal (3D7; Cell Signal-
ing Technology), anti-p38 rabbit polyclonal (Cell Signaling Technology), 
anti–phospho-HtrA2/Omi (Ser 142) rabbit polyclonal, anti-HtrA2/Omi 
goat polyclonal (V-17; Santa Cruz Biotechnology, Inc.), anti-p53 mouse 
monoclonal (1C12; Cell Signaling Technology), anti–-actin mouse mono-
clonal (ACTBD11B7; Santa Cruz Biotechnology, Inc.), anti-COX IV rabbit 
polyclonal (ab16056; Abcam), anti–caspase-3 rabbit polyclonal (Cell Sig-
naling Technology), anti-cleaved caspase-3 rabbit monoclonal (5A1E; Cell 
Signaling Technology), anti-Flag mouse monoclonal (M2; Sigma-Aldrich), 
anti–-tubulin mouse monoclonal (DM1A; Sigma-Aldrich), and anti-GAPDH 
mouse monoclonal (6C5; Life Technologies) antibodies were used for im-
munoblot analysis. Anti–phospho-p130Cas (Tyr 165) rabbit polyclonal 
(Cell Signaling Technology) and anti-p53 mouse monoclonal (DO-1; Santa 
Cruz Biotechnology, Inc.) antibodies were used for immunoblot and 
immunofluorescence analyses. Anti-HtrA2/Omi rabbit polyclonal (R&D Sys-
tems), anti-paxillin mouse monoclonal (BD), and anti–cytochrome c mouse 
monoclonal (6H2; Santa Cruz Biotechnology, Inc.) antibodies were used for 
immunofluorescence analysis. Anti-p130Cas (Cas3) antibody was gener-
ated against a bacterially expressed fragment of p130Cas as described 
elsewhere (Sakai et al., 1994). Anti–phospho-HtrA2/Omi (Ser 142) anti-
body was generated against the phosphopeptide SPPPA(pS)PRSQYC (a gift 
from Hélène Plun-Favreau, University College London, London, England, UK). 
Ucf-101, blebbistatin, and Adriamycin were purchased from EMD Millipore. 
BIRB796 was purchased from LC Laboratories. Cytochalasin D, latrunculin A, 
jasplakinolide, Q-VD-OPh, carbonyl cyanide 3-chlorophenylhydrazone 
(CCCP), carbonyl cyanide 4-trifluoromethoxyphenylhydrazone (FCCP), 
and oligomycin were purchased from Sigma-Aldrich.
Immunoblot analysis
Cells were solubilized with ice-cold lysis buffer (50 mM Tris, pH 8.0, 150 mM 
NaCl, 1% Triton X-100, 0.5% SDS, 10 mM EDTA, 1 mM Na3VO4, 10 mM 
NaF, and protease inhibitor cocktail [Nacalai Tesque]). Lysates were sonicated 
and centrifuged at 20,000 g for 20 min. The supernatants were then sub-
jected to SDS-PAGE. For immunoblotting against -actin, cells were solubi-
lized with SDS sample buffer. For immunoblotting against phosphorylated 
HtrA2/Omi for total cell lysates, cells were solubilized with 1% CHAPS lysis 
buffer (1% CHAPS, 20 mM Tris, pH 7.4, 137 mM NaCl, 1 mM EDTA, and 
10% glycerol).
Live-cell imaging
Protrusions of cells expressing Lifeact-GFP (a gift from Roland Wedlich-Söldner, 
University of Munster, Munster, Germany; Riedl et al., 2008) in cell culture 
medium were observed with a spinning-disk confocal microscopy system 
(UltraVIEW VoX; PerkinElmer) with an inverted microscope (model IX81; 
Olympus), a 100× NA 1.40 oil immersion UPlanSApo objective (Olym-
pus), and an electron multiplying charge-coupled device 14-bit 1K × 1K 
camera (ImagEM-1K C9100-50; Hamamatsu Photonics) at 37°C in 5% CO2. 
A 488-nm laser was used for imaging. Images were acquired at an inter-
val of 10 s for 5 min and then exported as TIFF files using Volocity software 
(version 6.0.1; PerkinElmer). All images were cropped and converted to 
AVI files using ImageJ (version 1.45f; National Institutes of Health). To ob-
serve localization of Bax, GFP-Bax, and DsRed-Mito were simultaneously 
visualized with the same microscope setup as that for Lifeact-GFP except 
that an electron multiplying charge-coupled device 16-bit 512 × 512 cam-
era (ImagEM-Enhanced C9100-13; Hamamatsu Photonics) was used.
Immunofluorescence
Immunofluorescence staining for p130Cas or paxillin was performed as de-
scribed previously (Kawauchi et al., 2012). Cells were fixed with 4% PFA, 
permeabilized with 0.2% Triton X-100, and then blocked with 2% BSA in 
cytoskeletal stabilizing buffer (137 mM NaCl, 5 mM KCl, 1.1 mM sodium 
phosphate [dibasic], 0.4 mM monopotassium phosphate, 4 mM sodium bi-
carbonate, 2 mM MgCl2, 5.5 mM glucose, 2 mM EGTA, and 5 mM Pipes, 
pH 6.1). Alexa Fluor 488– or 546–conjugated goat anti–mouse and anti–
rabbit IgG (Molecular Probes) were used as secondary antibodies. Alexa 
Fluor 488– or 594–conjugated phalloidin (Molecular Probes) was used to 
stain F-actin. For immunofluorescence against cytochrome c, cells were cul-
tured in the presence or absence of 100 µM Q-VD-OPh for 12 h, fixed with 
4% PFA, permeabilized with 100% methanol, and then blocked with 2% 
BSA in PBS. Alexa Fluor 546–conjugated goat anti–mouse IgG was used as 
However, results using primary p53/ MEFs or p53R175H- 
introduced NIH3T3 cells support our provided model that p53 
hampers Ras-driven invasion via HtrA2/Omi-mediated cleav-
age of -actin when the ability of p53 to suppress tumorigenesis 
is somehow compromised.
p130Cas and FAK are localized at FAs and cooperate to 
promote cancer cell invasion (Wang and McNiven, 2012). In-
crease in cellular tension is known to induce activation of FAK, 
which subsequently induces autophosphorylation at Tyr397, 
leading to the recruitment of various proteins to FAs, including 
p130Cas (Parsons et al., 2010). Interestingly, their regulation in 
Ras-transformed cells appears to be different. FAK phosphory-
lation was slightly decreased in Ras-transformed cells irrespective 
of p53 expression, whereas p130Cas phosphorylation was de-
creased only in Ras-transformed cells expressing p53 (Fig. 2 C). 
Phosphorylation of both FAK and p130Cas was significantly de-
creased by the inhibition of actin polymerization in nontrans-
formed cells (Fig. 3 A). Importantly, the amount of F-actin in 
p53/ MEFs was not affected by transformation (Fig. 3 D) and 
therefore oncogenic Ras-mediated down-regulation of FAK 
phosphorylation is not caused by the inhibition of actin polymer-
ization. A Ras-induced reduction in traction force exertion, which 
is associated with actomyosin contractility (Moore et al., 2010), 
was observed in both NIH3T3 cells and p53/ MEFs (Fig. S1, 
E and F), and may therefore, at least in part, be involved in the de-
crease in FAK phosphorylation. In addition, FAK phosphorylation 
is regulated independently of focal adhesion regulation (Zheng 
et al., 2009). Taken together, p130Cas promotes cell invasion of 
Ras-transformed cells, without a correlation in FAK activity.
Here, we propose a novel role of p53 in dictating the ma-
lignant phenotype of oncogenic Ras-transformed cells. The evi-
dence presented in this study highlights the importance of p53 
in the regulation of the actin cytoskeleton via disruption of mi-
tochondrial integrity.
Materials and methods
Cell culture and retroviral infection
Cells were cultured in DMEM supplemented with 10% FBS (Biowest). Immor-
talized wild-type MEFs were described elsewhere (Su et al., 1999). p53/ 
MEFs were prepared as described previously (Kawauchi et al., 2008) and 
infected after two passages. We performed all experiments within two weeks 
after selection to avoid genetic abnormalities acquired during prolonged 
culture. Retroviral infection was performed as described previously (Kawauchi 
et al., 2008). Infected cells were selected using 300 µg/ml hygromycin and 
1.5 µg/ml puromycin for 3 d, and 500 µg/ml zeocin and 500 µg/ml neo-
mycin for 7 d.
Plasmids
To generate retroviruses encoding shRNAs against HtrA2/Omi and 
p130Cas, the HtrA2/Omi target sequence, 5-CACACTGAGGATTCAAAC-
CAA-3, and p130Cas target sequence, 5-GCATGACATCTACCAAGTT-3, 
were cloned into a pSuper puro (Oligoengine) or pSINsi (Takara Bio Inc.) 
vector. pBabe Ha-RasV12 with a hygromycin selection marker and pBabe 
p53R175H with a zeocin selection marker were used (Kawauchi et al., 
2008). pBabe p53KRKKK, which contains K305A, R306A, K319A, K320A, 
and K321A substitutions in NLS (O’Keefe et al., 2003), was generated from 
pBabe p53 with a puromycin selection marker. The mature forms of mouse 
HtrA2/Omi cDNA were obtained by PCR from NIH3T3 cDNA pools and 
cloned into a pCMV-Flag vector. pCMV-Flag-mature HtrA2/Omi was then 
generated with either the S142D or S306A mutation, where Ser 142 or Ser 
306 of HtrA2/Omi was replaced by aspartic acid or alanine, respectively. 
The Mito-DsRed expression vector was obtained from Takara Bio Inc.
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were measured using ImageJ software (version 1.45f). The ratio of cells 
that had invaded 30 µm or more was calculated.
Purification of HtrA2/Omi proteins
HEK293T cells were transfected with pCMV-Flag-mature HtrA2/Omi and solu-
bilized with ice-cold lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% Tri-
ton X-100, 10 mM EDTA, 1 mM Na3VO4, 10 mM NaF, and protease inhibitor 
cocktail). Lysates were centrifuged at 20,000 g for 20 min at 4°C. The Flag-
mature HtrA2/Omi were captured on anti-Flag M2 affinity gel (Sigma-Aldrich) 
and eluted by competition with free 3× Flag peptide (Sigma-Aldrich) dissolved 
in TBS buffer (50 mM Tris, pH 7.4, and 150 mM NaCl) for 3 h at 4°C.
In vitro F-actin severing
Chamber slides were coated with 1% 3-triethoxysilylpropylamine in metha-
nol for 1 h and 0.11% biotin-polyethylene glycol (PEG) and 4.4% mPEG 
(Laysan Bio) in 100 mM Na2CO3 for 2 h at room temperature. The coated 
chamber slides were blocked with 4% BSA in PBS overnight and incubated 
with 10 ng/ml NeutrAvidin (Thermo Fisher Scientific) for 5 min at room 
temperature. 0.6 µM actin, 0.03 µM biotin-labeled actin (Cytoskeleton, 
Inc.), and 0.14 µM Alexa Fluor 488–conjugated actin (Molecular Probes) 
were converted into Mg2+-actin in Mg2+ buffer (2 mM Tris, pH 8.0, 0.1 mM 
MgCl2, 1 mM DTT, 0.4 mM ATP, and 0.01% NaN3) and polymerized in 
1× KMEI (50 mM KCl, 1 mM MgCl2, 1 mM EGTA, and 10 mM imidazole, 
pH 7.0). We included 3 mg/ml glucose and catalase/glucose oxidase 
(Sigma-Aldrich) to prevent photobleaching and 20 mM phosphoenol 
(Sigma-Aldrich), 100 U/ml pyruvate kinase (Sigma-Aldrich), and 10 mM 
KCl to regenerate ATP. The polymerized actin was attached to the chamber 
slides through biotin-NeutrAvidin interactions and incubated with 0.2 µM 
purified HtrA2/Omi at room temperature. Images of the polymerized actin 
in 4% BSA containing PBS were acquired using a total internal reflection 
fluorescence (TIRF) microscopy system (Nikon) with an inverted microscope 
(Eclipse Ti-E; Nikon), a 100× NA 1.49 oil immersion CFI Plan Apochromat 
TIRF objective (Nikon), and an electron multiplying charge-coupled device 
16-bit 512 × 512 camera (iXon3 897; Andor Technology) at room tem-
perature. A 488-nm laser was used for imaging. Images were acquired at 
an interval of 15 s for 1 h using NIS-Elements imaging software (version 
4.13.01). Fluorescence intensities of images were quantified and con-
verted to AVI files using ImageJ software (version 1.45f).
Traction force microscopy
Polyacrylamide substrates were prepared on 25-mm glass coverslips. 40 µl of 
mixed acrylamide solution containing 5% acrylamide, 0.1% N,N-methylene-
bis-acrylamide (BIS), 0.2% TEMED, 0.1% wt/vol APS, and a 1:500 dilution 
of latex microspheres (Fluoresbrite Plain YG 0.2-µm microspheres; Poly-
sciences) was applied onto a coverslip silanized with 3-methacryloxy-
propyltrimethoxysilane and allowed to polymerize evenly by covering with 
another untreated coverslip. Type-I collagen (Koken Co.) was covalently at-
tached to the surface of the gel using the photoactivatable cross-linker sulfo-
SANPAH (Thermo Fisher Scientific). Cells were seeded onto polyacrylamide 
substrates in cell culture medium. Images were acquired using a spinning-
disk confocal microscopy system (UltraVIEW VoX; PerkinElmer) with an in-
verted microscope (model IX81; Olympus), a 20× NA 0.70 water immersion 
UApoN340 objective (Olympus), and an electron multiplying charge-coupled 
device 14-bit 1K × 1K camera (ImagEM-1K C9100-50; Hamamatsu Pho-
tonics) at 37°C with 5% CO2. Images of a cell and latex microspheres 
before and after cell detachment with trypsin were acquired with differential 
interference contrast (DIC) and 440-nm laser, respectively, using Volocity 
software (version 6.0.1). Once the entire displacement field was calculated 
from images of latex microspheres using MATLAB software (version R2012a), 
the traction stress field was obtained as the solution to the inverse Boussinesq 
problem as described previously (Yip et al., 2013).
F-actin sedimentation assay
F-actin and G-actin were isolated as described previously with a slight modi-
fication (Kiuchi et al., 2007; Akin and Mullins, 2008). Cells were solubilized 
with ice-cold lysis buffer (50 mM Hepes, pH 7.4, 100 mM NaCl, 1 mM 
MgCl2, 0.2 mM CaCl2, 1 mM DTT, 1% NP-40, 2 µM phalloidin [Sigma-
Aldrich], and 2 µM latrunculin B [EMD Millipore]). Lysates were centrifuged 
at 100,000 g for 30 min at 4°C. Equal amounts of pellet (F-actin) and super-
natant (G-actin) were subjected to SDS-PAGE. Blots against actin (Cytoskele-
ton, Inc.) were quantified using ImageJ software.
Monitoring mitochondrial membrane potential
Cells were cultured on glass-bottom dishes in the presence of JC-1 (2 µM; 
Molecular Probes), a cationic dye that accumulates in energized mitochon-
dria, for 30 min. Images of cells in PBS were acquired using a confocal 
a secondary antibody. Immunofluorescence staining for exogenous p53 was 
performed as for p130Cas, except that PBS was used instead of cytoskeletal 
stabilizing buffer. Alexa Fluor 488–conjugated goat anti–mouse IgG was 
used as secondary antibody. Images of cells in PBS were acquired using a 
confocal microscopy system (A1Rsi; Nikon) with an inverted microscope 
(Eclipse Ti-E; Nikon), a 100× NA 1.40 Plan Apochromat VC objective 
(Nikon), and an electron multiplying charge-coupled device 12-bit 512 × 
512 camera (DU897; Andor Technology) at RT. Both 488- and 561-nm la-
sers were used for imaging. Images were acquired using NIS-Elements imag-
ing software (version 4.10.00; Nikon). Acquired images were cropped 
using ImageJ software (version 1.45f). Immunofluorescence staining for 
HtrA2/Omi was performed as for p53. Cells in PBS were observed with a 
spinning-disk confocal microscopy system (UltraVIEW VoX; PerkinElmer) with 
an inverted microscope (model IX81; Olympus), a 100× NA 1.40 oil immer-
sion UPlanSApo objective (Olympus), and an electron multiplying charge-
coupled device 14-bit 1K × 1K camera (ImagEM-1K C9100-50; Hamamatsu 
Photonics) at 37°C with 5% CO2. Both 488- and 561-nm lasers were used 
for imaging. Images were acquired and then exported as TIFF files using 
Volocity software (version 6.0.1). Images were cropped and analyzed using 
ImageJ software (version 1.45f). To evaluate the release of HtrA2/Omi from 
mitochondria into cytosol, fluorescence intensities of three areas (1 µm in di-
ameter) devoid of Mito-DsRed fluorescence in each cell were quantified.
Super-resolution imaging of mitochondria
The spatial organization of mitochondria in live cells expressing Mito-DsRed 
in cell culture medium was analyzed using a three-dimensional structure il-
lumination microscopy system (N-SIM; Nikon) with an inverted microscope 
(Eclipse Ti-E; Nikon), a 100× NA 1.49 oil immersion CFI Plan Apo IR objec-
tive (Nikon), and an electron multiplying charge-coupled device 16-bit 512 × 
512 camera (iXon3 897; Andor Technology) at 37°C with 5% CO2. A 561-nm 
laser was used for imaging. Images were acquired using NIS-Elements imag-
ing software (version 4.11.00). Reconstructed z-stack images were segmen-
talized and analyzed using Imaris (Bitplane AG). Each mitochondrion was 
identified and fitted with a single ellipsoidal object. The length (along the 
long-axis) of each ellipsoid-fitted mitochondrion was measured (defined as 
mitochondria length) and then used to compare differences in mitochondrial 
shape. The cumulative normalized distribution of mitochondria length was 
analyzed and plotted with the SEM in Prism (GraphPad Software).
Subcellular fractionation
Mitochondria were isolated using a mitochondria isolation kit (QIAGEN) ac-
cording to the manufacturer’s protocol. The isolated mitochondrial fraction 
was solubilized with ice-cold lysis buffer (50 mM Tris, pH 8.0, 150 mM 
NaCl, 1% Triton X-100, 10 mM EDTA, 1 mM Na3VO4, 10 mM NaF, and 
protease inhibitor cocktail).
Analysis of F/G-actin ratio
Analysis of the F/G-actin ratio was performed as described previously 
(Kawauchi et al., 2012). F-actin and G-actin were stained with Alexa Fluor 
488–phalloidin and Alexa Fluor 594–DNase I, respectively. Epifluorescence 
images of cells in PBS were acquired using a confocal microscopy system 
(A1Rsi; Nikon) with an inverted microscope (Eclipse Ti-E; Nikon), a 60× NA 
1.40 CFI Plan Apochromat VC oil immersion objective (Nikon), and an elec-
tron multiplying charge-coupled device 16-bit 512 × 512 camera (DU897; 
Andor Technology) at RT. Both 488- and 561-nm lasers were used for imag-
ing. Images were acquired using NIS-Elements imaging software (version 
4.10.00). Acquired images were analyzed using ImageJ software (version 
1.45f). The intensity ratios of F/G-actin were calculated for each pixel and 
the calculated values were averaged within individual cell regions.
Inverted invasion assay
Matrigel (BD) supplemented with 25 µg/ml fibronectin (EMD Millipore) 
was polymerized in 8-µm pore-sized Transwell inserts (Corning) for 1 h at 
37°C. The Transwell inserts were inverted before 3 × 104 cells labeled with 
carboxyfluorescein diacetate succinimidyl ester (CFDA-SE; Molecular 
Probes) were seeded onto the base of each insert. After incubating for 6 h 
at 37°C, the Transwell inserts were placed in serum-free medium. To estab-
lish a chemotactic gradient, medium supplemented with 10% FBS and 
50 ng/ml EGF was added to the upper chamber. Cells were allowed to in-
vade into the Matrigel for 72 h at 37°C. Images of cells in the Transwell in-
serts were acquired using a confocal microscopy system (A1Rsi; Nikon) 
with an inverted microscope (Eclipse Ti-E; Nikon), a 20× NA 0.75 Plan 
Apochromat VC objective (Nikon), and an electron multiplying charge-
coupled device 16-bit 512 × 512 camera (DU897; Andor Technology) at 
RT. A 488-nm laser was used for imaging. Images were acquired at 10-µm 
intervals using NIS-Elements imaging software (version 4.10.00). Cell areas 
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microscopy system (A1Rsi; Nikon) with an inverted microscope (Eclipse Ti-
E; Nikon), a 40× NA 0.95 Plan Apochromat objective (Nikon), and an 
electron multiplying charge-coupled device 16-bit 512 × 512 camera 
(DU897; Andor Technology) at 37°C with 5% CO2. Both 488- and 561-
nm lasers were used for imaging monomers and J-aggregate forms, respec-
tively. Images were acquired using NIS-Elements imaging software (version 
4.10.00). Acquired images were cropped and fluorescence intensities 
were quantified using ImageJ software (version 1.45f).
Quantitative real-time PCR
Quantitative real-time PCR analysis was performed as described previously 
(Kawauchi et al., 2012). The following primers were used. Mouse PUMA 
forward 5-ACGACCTCAACGCGCAGTACG-3, reverse 5-GAGGAGT-
CCCATGAAGAGATTG-3; mouse BAX forward 5-CAGGATGCGTCCAC-
CAAGAA-3, reverse 5-AGTCCGTGTCCACGTCAGCA-3; and mouse 
cyclophilin A forward 5-CCTTGGGCCGCGTCTCCTT-3, reverse 5-CAC-
CCTGGCACATGAATCCTG-3. After normalization against cyclophilin A, 
mRNA expression levels relative to control expression levels were calcu-
lated for each experiment.
Statistical analysis
Data were analyzed by unpaired Student’s t test.
Online supplemental material
Fig. S1 shows that oncogenic Ras decreases cell-spreading area in a 
p130Cas-independent manner. Fig. S2 confirms that oncogenic Ras de-
creases the ratio of F/G-actin in a p53-dependent manner. Fig. S3 shows 
that caspase-3 is not involved in Ras-induced cleavage of -actin. Fig. S4 
suggests that the transcriptional activity of p53 is dispensable for Ras- 
induced translocation of p38 MAPK to mitochondria. Fig. S5 suggests 
roles for Bax and a decrease in oxidative phosphorylation in Ras-induced 
release of HtrA2/Omi. Video 1 shows actin filament dynamics in cell mem-
brane protrusions from a Ras-transformed NIH3T3 cell. Video 2 shows 
actin filament dynamics in cell membrane protrusions from a Ras-trans-
formed NIH3T3 cell expressing HtrA2/Omi-shRNA. Video 3 shows actin 
filament dynamics in cell membrane protrusions from a Ras-transformed 
NIH3T3 cell expressing HtrA2/Omi- and p130Cas-shRNA. Video 4 shows 
actin filament dynamics in cell membrane protrusions from a Ras-transformed 
NIH3T3 cell expressing p53R175H. Video 5 shows actin filament dynamics 
in cell membrane protrusions from a Ras-transformed NIH3T3 cell express-
ing p53R175H with p130Cas-shRNA. Video 6 shows images of F-actin 
incubated with wild-type HtrA2/Omi. Video 7 shows images of F-actin in-
cubated with HtrA2/Omi-S306A. Video 8 shows images of F-actin incu-
bated with HtrA2/Omi-S142D. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.201309107/DC1.
We thank L. Kenney, M. Sheetz, G.V. Shivashankar, B.C. Low, Y. Ito, K. Kohu, 
A. Bershadsky, S. Wolf, H. Machiyama, M. Sokabe, and Y. Nishimura for 
discussion; F.B. Abu Bakar for technical support; I. Uehara for preparation of 
p53–/–MEFs; R. Wedlich-Soldner for Lifeact-GFP expression vector; S. Hirose 
for pcDNA3-Flag Mfn2; and H. Plun-Favreau for anti–phospho-HtrA2/Omi 
antibody. All microscopy was carried out at the microscopy core facility, MBI, 
National University of Singapore.
This work was supported by the National Research Foundation, Singa-
pore, and the Ministry of Education, Singapore, through the Mechanobiology 
Institute; and a Kurata Grant from the Kurata Memorial Hitachi Science and 
Technology Foundation, Japan.
The authors declare no competing financial interests.
Submitted: 20 September 2013
Accepted: 26 February 2014
References
Akin, O., and R.D. Mullins. 2008. Capping protein increases the rate of actin-
based motility by promoting filament nucleation by the Arp2/3 complex. 
Cell. 133:841–851. http://dx.doi.org/10.1016/j.cell.2008.04.011
Albini, A., Y. Iwamoto, H.K. Kleinman, G.R. Martin, S.A. Aaronson, J.M. 
Kozlowski, and R.N. McEwan. 1987. A rapid in vitro assay for quantitat-
ing the invasive potential of tumor cells. Cancer Res. 47:3239–3245.
Cabodi, S., M. del Pilar Camacho-Leal, P. Di Stefano, and P. Defilippi. 2010. 
Integrin signalling adaptors: not only figurants in the cancer story. Nat. 
Rev. Cancer. 10:858–870. http://dx.doi.org/10.1038/nrc2967
Campbell, P.M., and C.J. Der. 2004. Oncogenic Ras and its role in tumor cell 
invasion and metastasis. Semin. Cancer Biol. 14:105–114. http://dx.doi 
.org/10.1016/j.semcancer.2003.09.015
1207p53 prevents cell invasion via activation of HtrA2 • Yamauchi et al.
Wang, Y., and M.A. McNiven. 2012. Invasive matrix degradation at focal ad-
hesions occurs via protease recruitment by a FAK-p130Cas complex. J. 
Cell Biol. 196:375–385. http://dx.doi.org/10.1083/jcb.201105153
Westermann, B. 2010. Mitochondrial fusion and fission in cell life and death. Nat. 
Rev. Mol. Cell Biol. 11:872–884. http://dx.doi.org/10.1038/nrm3013
Yamasaki, S., N. Yagishita, T. Sasaki, M. Nakazawa, Y. Kato, T. Yamadera, E. 
Bae, S. Toriyama, R. Ikeda, L. Zhang, et al. 2007. Cytoplasmic destruction 
of p53 by the endoplasmic reticulum-resident ubiquitin ligase ‘Synoviolin’. 
EMBO J. 26:113–122. http://dx.doi.org/10.1038/sj.emboj.7601490
Yip, A.K., K. Iwasaki, C. Ursekar, H. Machiyama, M. Saxena, H. Chen, I. 
Harada, K.H. Chiam, and Y. Sawada. 2013. Cellular response to substrate 
rigidity is governed by either stress or strain. Biophys. J. 104:19–29. 
http://dx.doi.org/10.1016/j.bpj.2012.11.3805
Zheng, Y., Y. Xia, D. Hawke, M. Halle, M.L. Tremblay, X. Gao, X.Z. Zhou, 
K. Aldape, M.H. Cobb, K. Xie, et al. 2009. FAK phosphorylation by 
ERK primes ras-induced tyrosine dephosphorylation of FAK mediated 
by PIN1 and PTP-PEST. Mol. Cell. 35:11–25. http://dx.doi.org/10.1016/j 
.molcel.2009.06.013
Muller, P.A., K.H. Vousden, and J.C. Norman. 2011. p53 and its mutants in 
tumor cell migration and invasion. J. Cell Biol. 192:209–218. http://
dx.doi.org/10.1083/jcb.201009059
Nakano, K., and K.H. Vousden. 2001. PUMA, a novel proapoptotic gene, is induced 
by p53. Mol. Cell. 7:683–694. http://dx.doi.org/10.1016/S1097-2765(01) 
00214-3
O’Keefe, K., H. Li, and Y. Zhang. 2003. Nucleocytoplasmic shuttling of p53 
is essential for MDM2-mediated cytoplasmic degradation but not ubiq-
uitination. Mol. Cell. Biol. 23:6396–6405. http://dx.doi.org/10.1128/ 
MCB.23.18.6396-6405.2003
Olson, M.F., and E. Sahai. 2009. The actin cytoskeleton in cancer cell motility. 
Clin. Exp. Metastasis. 26:273–287. http://dx.doi.org/10.1007/s10585-008- 
9174-2
Parsons, J.T., A.R. Horwitz, and M.A. Schwartz. 2010. Cell adhesion: integrat-
ing cytoskeletal dynamics and cellular tension. Nat. Rev. Mol. Cell Biol. 
11:633–643. http://dx.doi.org/10.1038/nrm2957
Pawlak, G., and D.M. Helfman. 2001. Cytoskeletal changes in cell transforma-
tion and tumorigenesis. Curr. Opin. Genet. Dev. 11:41–47. http://dx.doi 
.org/10.1016/S0959-437X(00)00154-4
Perumalsamy, L.R., M. Nagala, and A. Sarin. 2010. Notch-activated signaling 
cascade interacts with mitochondrial remodeling proteins to regulate cell 
survival. Proc. Natl. Acad. Sci. USA. 107:6882–6887. http://dx.doi.org/10 
.1073/pnas.0910060107
Petrie, R.J., and K.M. Yamada. 2012. At the leading edge of three-dimensional 
cell migration. J. Cell Sci. 125:5917–5926. http://dx.doi.org/10.1242/jcs 
.093732
Plun-Favreau, H., K. Klupsch, N. Moisoi, S. Gandhi, S. Kjaer, D. Frith, K. 
Harvey, E. Deas, R.J. Harvey, N. McDonald, et al. 2007. The mitochon-
drial protease HtrA2 is regulated by Parkinson’s disease-associated kinase 
PINK1. Nat. Cell Biol. 9:1243–1252. http://dx.doi.org/10.1038/ncb1644
Riedl, J., A.H. Crevenna, K. Kessenbrock, J.H. Yu, D. Neukirchen, M. Bista, 
F. Bradke, D. Jenne, T.A. Holak, Z. Werb, et al. 2008. Lifeact: a versa-
tile marker to visualize F-actin. Nat. Methods. 5:605–607. http://dx.doi 
.org/10.1038/nmeth.1220
Rivlin, N., R. Brosh, M. Oren, and V. Rotter. 2011. Mutations in the p53 
tumor suppressor gene: important milestones at the various steps of 
tumorigenesis. Genes Cancer. 2:466–474. http://dx.doi.org/10.1177/ 
1947601911408889
Sakai, R., A. Iwamatsu, N. Hirano, S. Ogawa, T. Tanaka, H. Mano, Y. Yazaki, and 
H. Hirai. 1994. A novel signaling molecule, p130, forms stable complexes 
in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent man-
ner. EMBO J. 13:3748–3756.
Sharma, A., and B.J. Mayer. 2008. Phosphorylation of p130Cas initiates Rac 
activation and membrane ruffling. BMC Cell Biol. 9:50. http://dx.doi.org/ 
10.1186/1471-2121-9-50
Sherr, C.J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 
12:2984–2991. http://dx.doi.org/10.1101/gad.12.19.2984
Su, J., M. Muranjan, and J. Sap. 1999. Receptor protein tyrosine phosphatase 
alpha activates Src-family kinases and controls integrin-mediated re-
sponses in fibroblasts. Curr. Biol. 9:505–511. http://dx.doi.org/10.1016/ 
S0960-9822(99)80234-6
Suzuki, Y., Y. Imai, H. Nakayama, K. Takahashi, K. Takio, and R. Takahashi. 
2001. A serine protease, HtrA2, is released from the mitochondria and 
interacts with XIAP, inducing cell death. Mol. Cell. 8:613–621. http://
dx.doi.org/10.1016/S1097-2765(01)00341-0
Tait, S.W., and D.R. Green. 2010. Mitochondria and cell death: outer membrane 
permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11:621–632. 
http://dx.doi.org/10.1038/nrm2952
Vande Walle, L., P. Van Damme, M. Lamkanfi, X. Saelens, J. Vandekerckhove, 
K. Gevaert, and P. Vandenabeele. 2007. Proteome-wide Identification of 
HtrA2/Omi Substrates. J. Proteome Res. 6:1006–1015. http://dx.doi.org/10 
.1021/pr060510d
Vande Walle, L., M. Lamkanfi, and P. Vandenabeele. 2008. The mitochondrial 
serine protease HtrA2/Omi: an overview. Cell Death Differ. 15:453–460. 
http://dx.doi.org/10.1038/sj.cdd.4402291
Vaseva, A.V., and U.M. Moll. 2009. The mitochondrial p53 pathway. Biochim. 
Biophys. Acta. 1787:414–420. http://dx.doi.org/10.1016/j.bbabio.2008.10.005
Vaseva, A.V., N.D. Marchenko, K. Ji, S.E. Tsirka, S. Holzmann, and U.M. 
Moll. 2012. p53 opens the mitochondrial permeability transition pore to 
trigger necrosis. Cell. 149:1536–1548. http://dx.doi.org/10.1016/j.cell 
.2012.05.014
Vousden, K.H., and D.P. Lane. 2007. p53 in health and disease. Nat. Rev. Mol. 
Cell Biol. 8:275–283. http://dx.doi.org/10.1038/nrm2147
Vuori, K., and E. Ruoslahti. 1995. Tyrosine phosphorylation of p130Cas and 
cortactin accompanies integrin-mediated cell adhesion to extracellu-
lar matrix. J. Biol. Chem. 270:22259–22262. http://dx.doi.org/10.1074/ 
jbc.270.38.22259
